VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,541,168 | -19.3% | 914,746 | -5.5% | 0.00% | -50.0% |
| Q2 2023 | $15,537,123 | +4823.3% | 968,045 | +2280.4% | 0.00% | – |
| Q1 2023 | $315,584 | +4.9% | 40,668 | +161.5% | 0.00% | – |
| Q4 2022 | $300,952 | -38.5% | 15,553 | -32.3% | 0.00% | – |
| Q3 2022 | $489,000 | +940.4% | 22,960 | +562.6% | 0.00% | – |
| Q2 2022 | $47,000 | -89.2% | 3,465 | -81.3% | 0.00% | – |
| Q1 2022 | $435,000 | -39.1% | 18,518 | -30.6% | 0.00% | – |
| Q4 2021 | $714,000 | +86.9% | 26,691 | +21.3% | 0.00% | – |
| Q3 2021 | $382,000 | +1491.7% | 22,006 | +1133.5% | 0.00% | – |
| Q2 2021 | $24,000 | – | 1,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |